Top Markets
#1 Black Phoenix Black Phoenix +736.58%
#2 Islamic Coin Islamic Coin +146.19%
#3 THORChain THORChain +26.54%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.17%
#5 MiL.k Alliance MiL.k Alliance +22.54%
#6 THORChain Yield THORChain Yield +19.87%
#7 Bless Bless +18.53%
#8 TENDIES TENDIES +16.52%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +14.30%
#10 The Black Bull The Black Bull +11.04%
Coin of the day
Black Phoenix Black Phoenix
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

MRTX
Rankning i aktier #5120
Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the... Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors driving cancer progression. Its pipeline features MRTX849, a KRAS G12C inhibitor currently undergoing Phase 1/2 clinical trials for a range of malignancies, including non-small cell lung, colorectal, and pancreatic cancers. Additionally, the company is advancing Sitravatinib, an investigational broad-spectrum kinase inhibitor, which has reached Phase 3 clinical trials specifically for non-small cell lung cancer. Mirati also has a KRAS G12D inhibitor program in its preclinical development phase. The company has forged a collaboration and licensing agreement with BeiGene, Ltd. for the development, manufacturing, and commercialization of sitravatinib. Established in 1995, Mirati Therapeutics, Inc. maintains its headquarters in San Diego, California.
Aktiekurs
$58.70
Senast synkroniserad: 2024-01-23
Marknadsvärde
$2.98B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Mirati Therapeutics, Inc. (MRTX)

Kategori

Healthcare
Vinst för Mirati Therapeutics, Inc. (MRTX)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Mirati Therapeutics, Inc. är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Mirati Therapeutics, Inc. från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH